No Detail Found!

Influence of hs-CRP, IL-6 and TNF-α and it's role in dyslipidemia and type 2 diabetes in population of Karachi, Pakistan

Author(s)
Muhammad Nisar Department of Physiology, University of Karachi,Karachi,Pakistan
Mehir-un-Nisa Iqbal Department of Physiology, University of Karachi,Karachi,Pakistan
Abstract
The present study was conducted to estimate the prevalence of pro-inflammatory cytokine interleukin-6, highly sensitive C-reactive protein, and tumor necrotic factor alpha and evaluate the association and role of these inflammatory markers in the pathogenesis of type 2 diabetes mellitus. A retrospective case-control study was conducted in Karachi. 400 individuals participated in the study having 200 diabetic patients and 200 controls. The subjects' profile and anthropometric indices were recorded and the levels of FPG, fasting insulin, lipid profile, IL-6, and hs-CRP were determined. Insulin resistance, beta-cell function and sensitivity were calculated by HOMA analysis using the HOMA calculator. Using independent t-test BMI, percent body fats, HbA1c, FPG, and fasting insulin were found significant (p<0.05). HOMA-IR, percent beta cell, total cholesterol, triglyceride, and HDL showed significant (p<0.05) results among cases and controls. Similarly, TNF-a and hs-CRP were also found significant (p<0.05) in cases than controls. Multiple linear regression was performed to predict the values of FPG, fasting plasma insulin, and IL-6. All models were statistically significant (p<0.05). The current study reveals that inflammation is the fundamental mechanism in obesityinduced insulin resistance, and T2DM, expanded fat stores in the body, and sedentary lifestyle are involved in the alteration of metabolic processes.
Publication Details
Page(s) 1217-1225
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 34, Issue: S3, Year: 2021

Request the full text from PASTIC

Keywords
Tumor necrotic factor-alpha, type 2 diabetes mellitus, Interleukin 6, homeostasis model assessments for insulin resistance, Highly sensitive C reactive protein
References
Akbarzadeh M,Eftekhari MH,Dabbaghmanesh MH,Hasanzadeh J,Bakhshayeshkaram M .2013 .Serum Il-18 and hs-CRP correlate with insulin resistance without effect of calcitriol treatment on type 2 diabetes. Iran J. Immunol., 10(3) : 167-176.
Al-Rashed F,Ahmad Z,Iskandar MA,Tuomilehto J,AlMulla F and Ahmad R J .2019 .TNF-alpha induces A pro-inflammatory phenotypic shift in monocytes through Acsl1: Relevance to metabolic inflammation. Cell. Physiol. Biochem., 52 : 397-407.
Anari R,Amani R,Latifi SM,Veissi M,Shahbazian H M .2017 .Association of obesity with hypertension and dyslipidemia in type 2 diabetes mellitus subjects. Diabetes Metab Syndr:, 11(1) : 37-41.
Andrews Guzman M and Arredondo Olguin M .2014 .Association between ferritin, high sensitivity Creactive protein (hs-CRP) and relative abundance of hepcidin mrna with the risk of type 2 diabetes in obese subjects. Nutr, 30(3) : 577-584.
Anjana M,Sandeep S,Deepa R,Vimaleswaran KS,Farooq S,Mohan V .2004 .Visceral and central abdominal fat and anthropometry in relation to diabetes in Asian Indians. Diabetes Care, 27(12) : 2948-2953.
Basit A,Askari S,Zafar J,Riaz M,Fawwad A,Members N A .2016 .NDSP 06: Prevalence and risk factors for obesity in urban and rural areas of Pakistan: A study from Second National Diabetes Survey of Pakistan (NDSP. Res. Clin. Pract, 15(1) : 19-25.
Catalina MOS,Redondo PC,Granados MP,Cantonero C,Sanchez-Collado J,Albarran L,Lopez JJ .2019 .New insights into adipokines as potential biomarkers for type-2 diabetes mellitus. Curr. Med, 26(22) : 4119-4144.
Chan M .2017 .Obesity and diabetes: The slow-motion disaster. Milbank Q, 95(1) : 11.
Cheng L,Zhuang H,Yang S,Jiang H,Wang S,Zhang J .2018 .Exposing the causal effect of c-reactive protein on the risk of type 2 diabetes mellitus: A mendelian randomization study. Frontiers in Genetics, 9(1) : 657.
De Maranon AM,Iannantuoni F,Abad-Jimenez Z,Canet F,Díaz-Pozo P,Lopez-Domenech S,Roldan-Torres I,Morillas C,Rocha M,Víctor VM .2020 .Association between proinflammatory markers, leukocyte-endothelium interactions, and carotid intima-media thickness in type 2 diabetes: Role of glycemic control. Clin. Med, 9(8) : 2522.
Demyanets S,Kaun C,Kaider A,Speidl W,Prager M,Oravec S,Hohensinner P,Wojta J,Rega-Kaun G .2020 .The pro-inflammatory marker soluble suppression of tumorigenicity-2 (St2) is reduced especially in diabetic morbidly obese patients undergoing bariatric surgery. Cardiovasc Diabetol, 19(1) : 26.
Elimam H,Abdulla AM,Taha IM .2019 .Inflammatory markers and control of type 2 diabetes mellitus. Diabetes Metab, 13(1) : 800-804.
Esser N,Legrand-Poels S,Piette J,Scheen AJ,Paquot N AJ .2014 .Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res. Clin. Prac, 105(2) : 141-150.
Fadaei R,Bagheri N,Heidarian E,Nouri A,Hesari Z,Moradi N,Ahmadi A,Ahmadi R .2020 .Serum levels of Il-32 in patients with type 2 diabetes mellitus and its relationship with tnf-alpha and I1-6. , 125(1) : 154832.
Fossati P and Prencipe L .1982 .Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin. Chem, 28(10) : 2077-2080.
Gastaldelli A .2008 .Abdominal fat: Does it predict the development of type 2 diabetes. , : .
Hedlund P .1961 .Clinical and experimental studies on creactive protein (acute phase protein). Acta Medica Scandinavica. Supplementum, 361 : 1-71.
Kishimoto T,Akira S,Taga T .1992 .Interleukin-6 and its receptor: A paradigm for cytokines. Science, 258(5082) : 593-597.
Lainampetch J,Panprathip P,Phosat C,Chumpathat N,Prangthip P,Soonthornworasiri N,Puduang S,Wechjakwen N,Kwanbunjan K .2019 .Association of tumor necrosis factor alpha, interleukin 6, and c-reactive protein with the risk of developing type 2 diabetes: A retrospective cohort study of rural thais. J. Diabetes Res., 9051929 : .
Lee C,Adler A,Sandhu M,Sharp S,Forouhi N,Erqou S,Luben R,Bingham S,Khaw K,Wareham N K .2009 .Association of c-reactive protein with type 2 diabetes: Prospective analysis and meta-analysis. Diabetologia, 52(3) : 1040-1047.
Levy JC,Matthews DR,Hermans MP .1998 .Correct homeostasis model assessment (Homa) evaluation uses the computer program. Diabetes Care, 21(12) : 2191-2192.
Marques-Vidal P,Bastardot F,Von Kanel R,Paccaud F,Preisig M,Waeber G,Vollenweider P .2013 .Association between circulating cytokine levels, diabetes and insulin resistance in a population-based sample (colaus study). Clin Endocrinol (Oxf), 78(2) : 232-241.
Milas O,Gadalean F,Vlad A,Dumitrascu V,Velciov S,Gluhovschi C,Bob F,Popescu R,Ursoniu S,Jianu DC,Matusz P,Pusztai AM,Secara A,Simulescu A,Stefan M,Patruica M,Petrica F,Vlad D,Petrica L D .2020 .Pro-Inflammatory cytokines are associated with podocyte damage and proximal tubular dysfunction in the early stage of diabetic kidney disease in type 2 diabetes mellitus patients. J. Diabetes Complications, 34(2) : 107479.
Mtintsilana A,Micklesfield LK,Chorell E,Olsson T,Shivappa N,Hebert JR,Kengne AP,Goedecke JH .2019 .Adiposity mediates the association between the dietary inflammatory index and markers of type 2 diabetes risk in middle-aged black south african women. Nutrients, 11(6) : 1246.
Nadeem A,Naveed AK,Hussain MM,Raza SI .2013 .Correlation of inflammatory markers with type 2 diabetes mellitus in Pakistani patients. J. Postgrad. Med, 27 : .
Organization WH .2003 .. The World Health Report 2003: Shaping The Future, World Health Organization., : .
Phosat C,Panprathip P,Chumpathat N,Prangthip P,Chantratita N,Soonthornworasiri N,Puduang S,Kwanbunjan K S .2017 .Elevated C-reactive protein, interleukin 6, tumor necrosis factor alpha and glycemic load associated with type 2 diabetes mellitus in rural thais: A cross-sectional study. Bmc Endocr Disord, 17(1) : 44.
Pickup JC .2004 .Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care, 27(3) : 813-823.
Pickup JC .2006 .Inflammatory markers and type 2 diabetes. Diabetes Technol The., 8, (1) : 1-6.
Shiwaku K,Anuurad E,Enkhmaa B,Nogi A,Kitajima K,Yamasaki M,Yoneyama T,Oyunsuren T,Yamane Y .2005 .predictive values of anthropometric measurements for multiple metabolic disorders in asian populations. Diabetes Res. Clin. Pract, 69(1) : 52-62.
Simental-Mendia LE,Lazalde B,Zambrano-Galvan G,Simental-Saucedo L,Rabago-Sanchez E,RodriguezMoran M,Guerrero-Romero F .2012 .Relation between c-reactive protein and impaired fasting glucose in obese subjects. Inflammation, 35 : 1742-6.
Singh R,Shaw J,Zimmet P .2004 .Epidemiology of childhood type 2 diabetes in the developing world. Pediatric Diabetes, 5(3) : 154-168.
Songa RM,Siddhartha K,Sudhakar K K .2013 .Lipidprofile in type2 diabetes mellitus with obesity. Bopams, 1(2) : 132-137.
Tangvarasittichai S,Pongthaisong S,Tangvarasittichai O .2016 .Tumor necrosis factor-alpha, interleukin-6, c-reactive protein levels and insulin resistance associated with type 2 diabetes in abdominal obesity women. Indian J. Clin Biochem., 31(1) : 68-74.
Trinder P .1969 .Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann.Clin. Bioch, 6(1) : 24-27.
Valtierra-Alvarado MA,Castaneda Delgado JE,RamirezTalavera SI,Lugo-Villarino G,Duenas-Arteaga F,Lugo-Sanchez A,Adame-Villalpando MS,RivasSantiago B,Enciso-Moreno J,Serrano CJ .2020 .Type 2 diabetes mellitus metabolic control correlates with the phenotype of human monocytes and monocyte-derived macrophages. J. Diabetes Complications, 34(11) : 107708.
0

Citations

0

Downloads

11

Views